These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 6891903

  • 1. [Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination].
    Pouillart P, Bretaudeau B, Palangie T, Jouve M, Garcia-Giralt E, Asselain B.
    Bull Cancer; 1982; 69(5):434-42. PubMed ID: 6891903
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S, Yeap B, Vogl S, Carbone P.
    Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766
    [Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.
    Bruckner HW, Ratner LH, Cohen CJ, Wallach R, Kabakow B, Greenspan EM, Holland JF.
    Cancer Treat Rep; 1978 Jul 15; 62(7):1021-3. PubMed ID: 688244
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ, Lele SB.
    Cancer Treat Rep; 1984 Dec 15; 68(12):1433-8. PubMed ID: 6439408
    [Abstract] [Full Text] [Related]

  • 5. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
    Morgan RJ, Braly P, Cecchi G, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Parker P, Stein A, Cho J, Smith E, Coluzzi P, Najera L, Johnson D, Womack E, Doroshow JH.
    Gynecol Oncol; 1999 Dec 15; 75(3):419-26. PubMed ID: 10600300
    [Abstract] [Full Text] [Related]

  • 6. [Clinical trial of cisplatin in the treatment of ovarian carcinoma].
    Yoshizawa H, Kanazawa K, Takeuchi S, Okamura Y, Goto S, Kajiwara T.
    Gan To Kagaku Ryoho; 1982 May 15; 9(5):822-30. PubMed ID: 6764112
    [Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trial.
    Alberts DS, Hilgers RD, Moon TE, Martimbeau PW, Rivkin S.
    Cancer Treat Rep; 1979 Feb 15; 63(2):301-5. PubMed ID: 109200
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T, Vance R, Puneky L, Khansur T.
    Gynecol Oncol; 1994 Dec 15; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemotherapy of advanced ovarian cancer.
    Martoni A, Cacciari N, Angelelli B, Zamagni C, Pannuti F.
    Front Biosci; 1997 Mar 15; 2():g20-6. PubMed ID: 9159262
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G.
    Semin Oncol; 1996 Apr 15; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
    Israël L, Lepage E, Breau JL, Aguilera J.
    Bull Cancer; 1982 Apr 15; 69(5):426-33. PubMed ID: 6891902
    [Abstract] [Full Text] [Related]

  • 20. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
    Young RC, Chabner BA, Hubbard SP, Fisher RI, Bender RA, Anderson T, Simon RM, Canellos GP, DeVita VT.
    N Engl J Med; 1978 Dec 07; 299(23):1261-6. PubMed ID: 101843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.